|
SocialPicks Sentiment:
N/A
** not enough data to be rated
|
This Quarter's Sentiment:
|
|
|
CPD Analysis & Videos »
CPD: Bull or Bear?
FDA Calendar Updates: AZN, BMY, OSUR, CPD, INSM, H. Lundbeck
CPD
|
|
|
+0.00%
in
0 minute
(closed on 06/25/09)
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-st...
|
Caraco Pharma (AMEX:CPD): Poised for a Turnaround
CPD
|
|
|
-42.82%
in
26 days
(closed on 06/25/09)
On 5/28/09, Caraco Pharma (AMEX:CPD) reported its fiscal year 2009 (FY09) results and provided an update on the status of a recently completed FDA inspection of the Company's manufacturing facilities in Detroit, MI. Net sales for CPD declined by 4% for FY09 to a level of $337.2M (versus $350.4M for FY08). The Company cited lower sales of its manufactured products, price erosion for both manufactured + distributed generic drugs, and a voluntary product recall (of heart drug digoxin) during late FY09 for the revenue shortfall. <> Net income decreased to $20.5M during FY09 compa...
|
Bullish on CPD ...
CPD
|
|
|
-11.65%
in
261 days
Caraco Pharmaceutical Laboratories, Ltd. engages in the development, manufacture, and marketing of generic, prescription, and over-the-counter pharmaceuticals. The company offers Allopurinol, an anti-gout; Amifostine for injection used as oncology adjunct; Amlodipine Besylate tablets, Atenolol, Carvedilol, and Metoprolol Tartrate, which are antihypertensive drug/beta blockers; Baclofen and Tizanidine, which are skeletal muscle relaxants; Carbamazepine, Gabapentin, Phenytoin Sodium extended release capsules, Zonisamide, and Oxcarbazepine, which are anticonvulsants; Carbidopa and Levodopa ER ...
|
Three Oversold Healthcare Catalyst Stocks
CPD
|
|
|
+10.40%
in
28 days
(closed on 04/09/09)
Three Oversold Healthcare Catalyst Stocks With the S&P 500 SPDR ETF (SPY) trading about 8% below its 50-day moving average (DMA), I went in search of oversold healthcare stocks trading at least 16% below their 50 DMA which have potential catalysts within the next six months that may provide some very nice returns. <> The Healthcare Sector SPDR (XLV) is trading about 12% below its 50 DMA amidst concerns of sweeping healthcare reform that would threaten the profits of health insurers, managed care companies, big pharma, and biotechs – although such concerns may be ove<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>...
|
Big Pharma Goes Generic
CPD
|
|
|
-6.02%
in
14 days
(closed on 03/12/09)
<> <> <> <> <> <>  Sanofi-Aventis (SNY) is now the 11 th largest generic drug maker in the world following its successful acquisition of Czech generic drug company Zentiva. As $70B in brand drug patents are set to expire through 2012, big pharma companies are hedging their bets through generic drug divisions, including Pfizer (PFE) - Greenstone, Novartis (NVS) - Sandoz, and the recently announced Merck (MRK) BioVent...
|
Caraco Pharma Awaits FDA Inspection in May
CPD
|
|
|
+0.76%
in
20 hours
(closed on 02/26/09)
By Mike Havrilla on 2/25/09 I spoke with the investor relations representative for Caraco Pharma (CPD) earlier this week and received some clarity on the expected timeline for resolving the major overhang on the stock price related to the FDA warning letter over Form 483 concerns by the agency stemming from quality control issues raised during an inspection of manufacturing facilities last year. <> Caraco has responded in full to the warning letter and the FDA will evaluate the corrective actions taken by the Company at its next s...
|
A 130/30 Pharma Trade
CPD
|
|
|
-2.22%
in
5 days
(closed on 02/25/09)
By Mike Havrilla on 2/20/09 ETF Innovators The tables at my website link below include 12 U.S. listed companies from the ETF Innovators Global Generic Drug Index along with seven brand drug companies, which are ranked in descending order based on their patent expiration exposure through the end of 2011 as a percentage of total trailing 12-month revenue. <> Investors who are bullish on the generic drug industry may consider implementing a 130/30 pharma trade by shorting any/all...
|
Caraco Pharma Awaits FDA Inspection
CPD
|
|
|
-17.35%
in
21 days
(closed on 02/20/09)
<> With shares of Hi-Tech Pharmacal (HITK) already up about 20% since I profiled the Company as a value play two days ago , investors interested in the small-cap generic drug industry should take a look at Caraco Pharma (CPD) today at around 5 bucks. CPD reported results for its fiscal 3Q09 yesterday, including $55.7M in revenue and net income of $5.1M, which was down from the year-ago period revenue of $81.9M and net income of $10.8M. The year-ago period benefited substantially from the 180-day exclusivity period associated with the gene...
|
Hi-Tech Pharmacal: Hi-Growth at a Value Price
CPD
|
|
|
-14.04%
in
2 days
(closed on 01/30/09)
<> 
<> With shares of Home Diagnostics (HDIX) surging by nearly 50% since I profiled the company in mid-December as a turnaround, value play from the ETF Innovators Healthcare Cost Containment Index ; a search for compelling values among these companies today led me to generic drug maker Hi-Tech Pharmacal (HITK).
Shares of HITK are down by about 10% in the past five days on light volume and no news headlines, providing a nice chance to accumulate some shares. The Company reported record quarterly revenue for i...
|
Healthcare Hot Spots Beyond Stem Cells
CPD
|
|
|
+8.57%
in
2 days
(closed on 01/28/09)
Beyond Stem Cells: Healthcare Hot Spots With the surprise announcement last week by Geron (GERN) that the FDA would allow human clinical trials for embryonic stem cells, all companies in the underlying ETF Innovators Index to track the space are screaming higher again today – led by the company with the biggest gains over the past year, StemCells (STEM). <> Below are three additional areas and associated companies for investors to consider in the search of the next hot s...
|
20 Emerging Healthcare Stocks to Watch in '09
CPD
|
|
|
-17.58%
in
16 days
(closed on 01/26/09)
<> As a follow-up to my most recent article on the buyout binge among bio-pharma and diagnostic companies, below is a basket of 20 stocks (listed randomly) to consider from the ETF Innovators Indexes of 250 companies which represent a mix of pending catalysts in the form of clinical trials or FDA decisions, innovative patent portfolios or drug discovery technology platforms, promising compounds in clinical development, and marketed therapeutic or diagnostic products. Click on any of the company names for links to all of my prev...
|
Nine for '09 Stock Picks Start Strong
CPD
|
|
|
-3.34%
in
2 days
(closed on 01/10/09)
<> 
The nine stock picks I posted in mid-December are off to a strong start in the new year, with seven of the stocks registering gains and a 14.5% gain for the group as an equal-weight average versus a 1.1% gain for the S&P 500 SPDR ETF (SPY). Click on any of the links below for my most recent articles on each company.
The four smallest, defensive healthcare stock picks are leading the group with an average gain of 30.6% thanks to an 87.3% gain for Javelin Pharma (JAV) and a 42.9% gain for Caraco Pharma (CPD) while...
|
Virtual Investing at UpDown and MarketGuru
CPD
|
|
|
+5.19%
in
6 days
(closed on 01/08/09)
<>  <> The accompanying table includes the stocks in my MarketGuru virtual portfolio under MikeHavRx , which I began about one week ago.
Below is my current UpDown virtual investing portfolio, which is positioned to add some more offensive stock picks such as CME and Apple since it looks like the market rally is gaining momentum. Click on any of the company names below for a link to all of my articles.
Start earning real money with zero risk while improving your trading skills and strategies at the <> UpDow...
|
Five Top Rated Healthcare Cost Containment Stocks
CPD
|
|
|
+15.16%
in
2 days
(closed on 01/02/09)
The table at my website link below includes statistics and the top five rated companies in the ETF Innovators [ETFI] Global Healthcare Cost Containment Index. The index includes generic drug companies such as Teva Pharma (TEVA) and Perrigo (PRGO) as well as pharmacy benefit managers such as Express Scripts (ESRX), which share the common theme of promoting the use of generics to lower healthcare costs. http://www.etfinnovators.com/2008/12/five-top-rated-healthcar... <> <> The Top 40 Rated companies outpaced the overall market and benchmark healthcare ETFs over the past year w...
|
People Bullish on CPD
People Bearish on CPD
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Be the first to start a discussion and earn 2 points.
More Resources
|
About Caraco Pharmaceutical Labortories Ltd
- Answers.com
